<DOC>
	<DOCNO>NCT02780427</DOCNO>
	<brief_summary>The median effective dose ( ED50 ) ED95 intranasal dexmedetomidine single bolus describe sedation child undergo transthoracic echocardiography ( TEE ) study . This information important compare agent determine effective sedative dose . The investigator perform two-stage study determine ED50 ED95 intranasal dexmedetomidine investigate age-related difference participant undergo transthoracic echocardiography study .</brief_summary>
	<brief_title>ED50 ED95 Intranasal Dexmedetomidine Pediatric Patients Undergoing Transthoracic Echocardiography Study</brief_title>
	<detailed_description>The investigator perform two-stage study determine ED50 ED95 intranasal dexmedetomidine child undergo transthoracic echocardiography study . In phase 1 , 120 participant randomize Dixon-Massey study describe minimum local sedative dose . In phase 2 , 160 participant randomly allocate receive sedation dose upper dose-response range define ED95</detailed_description>
	<mesh_term>Dexmedetomidine</mesh_term>
	<criteria>Children , age one 36 month . classify ( American Society Anesthesiologists ) ASA physical status I II , undergo TEE enrol study . Known allergy hypersensitive reaction dexmedetomidine Organ dysfunction , significant developmental delay behavior problem Cardiac arrhythmia Known . acyanotic congenital heart disease child cardiac interventional procedure followup examination .</criteria>
	<gender>All</gender>
	<minimum_age>1 Month</minimum_age>
	<maximum_age>36 Months</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Dose-Response Relationship , Drug</keyword>
</DOC>